搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
The Pharma Letter
1 小时
NIH study shows mpox vaccine safe and effective in adolescents
A new NIH clinical trial shows the Jynneos (MVA-BN) vaccine is safe for adolescents and produces an antibody response similar ...
The Pharma Letter
1 小时
Rapid rise of COPD market predicted—despite barriers to growth
The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM) is set to grow from $11.5 billion in ...
The Pharma Letter
1 小时
FDA slaps CRL on Novavax' COVID-19 flu combo trial IND
Shares of US protein-based vaccine maker Novavax closed down 19.4% at $10.15 yesterday having dropped as much as 24%, on the ...
The Pharma Letter
4 小时
Shionogi presents largest global real-world evidence study of cefiderocol
Japanese drug major Shionogi has announced new data at IDWeek 2024 from PROVE (Retrospective Cefiderocol Chart Review), the largest global real-world evidence study of Fetroja/Fetcroja (cefiderocol), ...
The Pharma Letter
4 小时
FDA guidance for reconsideration at the division level under GDUFA
The US Food and Drug Administration (FDA) yesterday published the guidance for industry, “Requests for Reconsideration at the ...
The Pharma Letter
4 小时
Wave Life soars on positive early data for WVE-006
US RNA medicines biotech Wave Life Sciences yesterday announced positive proof-of-mechanism data from the ongoing Phase ...
The Pharma Letter
5 小时
Sanofi and Orano Med partner on next-gen radioligand therapies
Sanofi has partnered with Orano Med, a subsidiary of Orano Group, to develop radioligand therapies for rare cancers. Sanofi ...
The Pharma Letter
21 小时
Expert's optimism at ‘maturing’ of cell and gene therapy field
At the European Cell and Gene Therapy Summit 2024, confidence in the sector’s maturity and progress was evident, highlighted ...
The Pharma Letter
22 小时
ViiV Healthcare’s Apretude shows over 99% effectiveness in real-world studies
ViiV Healthcare, the specialist HIV company majority owned by GSK (LSE: GSK), today announced the presentation of new ...
The Pharma Letter
1 天
"Chemo mouth" treatment Gelclair launches in USA
California-based Jaguar Health today announced the US launch of Gelclair, the only Food and Drug Administration ...
The Pharma Letter
1 天
Forbion’s largest fundraiser yet exceeds two billion euros
Netherlands-based venture capital firm Forbion has raised over €2 billion ($2.2 billion) across its newest funds, bringing ...
The Pharma Letter
1 天
American Lung Association invests $22 million in research
The American Lung Association Research Institute has announced a $22 million investment in 2024 to fund 139 research grants ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈